Movatterモバイル変換


[0]ホーム

URL:


Jump to content
WikipediaThe Free Encyclopedia
Search

Syncona

From Wikipedia, the free encyclopedia
British investment trust
Syncona
Company typePublic
LSESYNC
FTSE 250 component
Founded2012; 14 years ago (2012)
Headquarters,
Key people
Melanie Gee (chair)
Websitewww.synconaltd.com

Syncona (LSESYNC) is a largeBritish closed-endedinvestment trust dedicated to life science investments. Co-founded as Syncona Partners in 2012 by former CEO Martin Murphy and the Wellcome Trust,[1] before merging with the Battle Against Cancer Investment Trust ('BACIT') in December 2016 and listing publicly,[2] the company is listed on theLondon Stock Exchange and is a constituent of theFTSE 250 Index.[3] Its Chair is Melanie Gee.[4]

References

[edit]
  1. ^"Wellcome Trust charity cuts stake in Syncona".Quoted Data. 14 March 2019. Retrieved3 October 2025.
  2. ^"U.K. investors team up to create $1.2B cancer-focused fund".Fierce Biotech. 7 November 2016. Retrieved3 October 2025.
  3. ^"BACIT Changes Name To Syncona After Investment Shift". Morning Star. 19 December 2016. Retrieved4 March 2017.
  4. ^"Tigue exiting Syncona as investment banker Gee joins board".Citywire. 6 June 2019. Retrieved5 August 2021.

External links

[edit]
FTSE 100FTSE 250 companies of the United Kingdom →FTSE SmallCap
Retrieved from "https://en.wikipedia.org/w/index.php?title=Syncona&oldid=1326921948"
Categories:
Hidden categories:

[8]ページ先頭

©2009-2026 Movatter.jp